Literature DB >> 15332232

A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.

Maxwell E Fisher1, Michele Rossini, Edith Simmons, Raymond C Harris, Gilbert Moeckel, Roy Zent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332232

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  6 in total

1.  Collapsing glomerulopathy as a complication of interferon therapy for hepatitis C infection.

Authors:  Sriraj Kanungo; Srinath Tamirisa; Rajalakshmi Gopalakrishnan; Luis Salinas-Madrigal; Bahar Bastani
Journal:  Int Urol Nephrol       Date:  2009-06-04       Impact factor: 2.370

Review 2.  De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

Authors:  Fabrizio Fabrizi; Alessio Aghemo; Gabriella Moroni; Patrizia Passerini; Roberta D'Ambrosio; Paul Martin; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.487

Review 3.  Anti-hepatitis C virus drugs and kidney.

Authors:  Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2016-11-18

4.  Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.

Authors:  Iram Gull; Muhammad Shahbaz Aslam; Imran Tipu; Roohi Mushtaq; Tehseen Zamir Ali; Muhammad Amin Athar
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

5.  HCV infection complicated with nephrotic syndrome, immune complex crescentic glomerulonephritis and acute renal failure: a case report.

Authors:  Yi-Chun Chen; Mei-Chuan Kuo; Hung-Chun Chen; Yung-Hsiung Lai; Shang-Jyh Hwang
Journal:  Kaohsiung J Med Sci       Date:  2005-10       Impact factor: 2.744

Review 6.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.